|
|
||||||||
Papers In Press, published online ahead of print May 24, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Laboratory Medicine, Clinical Chemistry, Malmö University Hospital, Malmo 20502
Corresponding Author: bjorn.dahlback{at}med.lu.se
Apolipoprotein M (apoM) is a plasma protein mainly associated with HDL. ApoM is suggested to be important for the formation of pre-ß HDL, but its mechanism of action is unknown. Homology modeling has suggested apoM to be a lipocalin. Lipocalins share a structurally conserved ß-barrel, which in many lipocalins bind hydrophobic ligands. The aim of the present study was to test the ability of apoM to bind different hydrophobic substances. ApoM was produced both in E. coli and in HEK 293 cells. Characterization of both variants with electrophoretic and immunological methods suggested apoM from E.coli to be correctly folded. Intrinsic tryptophan fluorescence of both apoM variants revealed that retinol, all-trans retinoic acid and 9-cis retinoic acid bound (Kd 2-3 µM), whereas other tested substances e.g. cholesterol, vitamin K and arachidonic acid did not. The intrinsic fluorescence of two apoM mutants carrying single tryptophans was quenched by retinol and retinoic acid to the same extent as wildtype apoM, indicating that the environment of both tryptophans was affected by the binding. In conclusion, the binding of retinol and retinoic acid supports the hypothesis that apoM is a lipocalin. The physiological relevance of this binding is yet to be elucidated.
Revised on May 23, 2007
Accepted on May 24, 2007
Hydrophobic ligand-binding properties of the human lipocalin apolipoprotein M
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Ahnstrom, O. Axler, M. Jauhiainen, V. Salomaa, A. S. Havulinna, C. Ehnholm, R. Frikke-Schmidt, A. Tybjaerg-Hansen, and B. Dahlback Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies J. Lipid Res., September 1, 2008; 49(9): 1912 - 1917. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Christoffersen, J. Ahnstrom, O. Axler, E. I. Christensen, B. Dahlback, and L. B. Nielsen The Signal Peptide Anchors Apolipoprotein M in Plasma Lipoproteins and Prevents Rapid Clearance of Apolipoprotein M from Plasma J. Biol. Chem., July 4, 2008; 283(27): 18765 - 18772. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Christoffersen, M. Jauhiainen, M. Moser, B. Porse, C. Ehnholm, M. Boesl, B. Dahlback, and L. B. Nielsen Effect of Apolipoprotein M on High Density Lipoprotein Metabolism and Atherosclerosis in Low Density Lipoprotein Receptor Knock-out Mice J. Biol. Chem., January 25, 2008; 283(4): 1839 - 1847. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Axler, J. Ahnstrom, and B. Dahlback An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma J. Lipid Res., August 1, 2007; 48(8): 1772 - 1780. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |